Sun Pharma

Five Indian firms ink licensing deal with MSD for COVID-19 drug molnupiravir: Report

Five Indian firms ink licensing deal with MSD for COVID-19 drug molnupiravir: Report

MSD Pharmaceuticals Pvt Ltd, a wholly-owned subsidiary of Merck Sharp & Dohme (MSD), has signed non-exclusive voluntary licensing agr...Read More

No plans to get into vaccine production as it requires separate manufacturing infrastructure, says Sun Pharma

No plans to get into vaccine production as it requires separate manufacturing infrastructure, says Sun Pharma

Sun Pharma has no immediate plans to enter into vaccine production as getting into the vertical would require an altogether different man...Read More

Stocks to Watch: UCO Bank, Max Healthcare, Gulf Oil, Sun Pharma, AstraZeneca Pharma, HeidelbergCement  among others

Stocks to Watch: UCO Bank, Max Healthcare, Gulf Oil, Sun Pharma, AstraZeneca Pharma, HeidelbergCement among others

Over the weekend, the finance ministry extended the scope of the Emergency Credit Line Guarantee Scheme (ECLGS). This decision is expecte...Read More

Sun Pharma acquires rights to trademarks of 3 diabetes drug brands in India from AstraZeneca

Sun Pharma acquires rights to trademarks of 3 diabetes drug brands in India from AstraZeneca

Drug major Sun Pharma on Friday said it has acquired the rights to trademarks of diabetes drug Dapagliflozin under brands Oxra, Oxramet a...Read More

Results: Sun Pharma Q4 net profit zooms over two-fold to Rs 894.15 crore

Results: Sun Pharma Q4 net profit zooms over two-fold to Rs 894.15 crore

Drug major Sun Pharmaceutical Industries on Thursday reported an over two-fold jump in consolidated net profit to Rs 894.15 crore for the...Read More

Sun Pharma recalls 50,868 bottles of diabetes drug in US

Sun Pharma recalls 50,868 bottles of diabetes drug in US

Drug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to ...Read More

After Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma, now Ipca Laboratories invests Rs 25 crore in ABCD Technologies

After Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma, now Ipca Laboratories invests Rs 25 crore in ABCD Technologies

Mumbai-based pharmaceuticals company Ipca Laboratories will complete the purchase of 4.03 per cent stake by April 30, 2021 in ABCD Techno...Read More

Sensex down 1400 points: Rising COVID-19 cases work in favour Sun Pharma, Cadila Healthcare, Fortis Healthcare, Vimta Labs, Solara Active Pharma stocks

Sensex down 1400 points: Rising COVID-19 cases work in favour Sun Pharma, Cadila Healthcare, Fortis Healthcare, Vimta Labs, Solara Active Pharma stocks

The rising COVID-19 cases in the country pulled the equity benchmark Sensex by over 1,400 points in early trade on Monday. While heavywei...Read More

Remdesivir shortage in Nagpur; Nitin Gadkari dials Sun Pharma chief

Remdesivir shortage in Nagpur; Nitin Gadkari dials Sun Pharma chief

Union minister Nitin Gadkari has called up Sun Pharma's chief to arrange for 10,000 injections of Remdesivir in Nagpur in view of a short...Read More

Sensex jumps over 300 pts: PowerGrid, M&M, NTPC, IndusInd Bank, Bajaj Finance, Sun Pharma, Dr Reddy's among gainers

Sensex jumps over 300 pts: PowerGrid, M&M, NTPC, IndusInd Bank, Bajaj Finance, Sun Pharma, Dr Reddy's among gainers

After starting on a weak note, equity benchmark Sensex rebounded over 300 points in early trade on Tuesday, tracking gains in index heavy...Read More

Eicher Motors, JSW Steel, Tata Motors, Hindalco, Tata Steel, Sun Pharma, Axis Bank and Tech Mahindra among others drove markets on Wednesday

Eicher Motors, JSW Steel, Tata Motors, Hindalco, Tata Steel, Sun Pharma, Axis Bank and Tech Mahindra among others drove markets on Wednesday

Equity benchmark indices closed half a per cent higher on Wednesday with IT, pharma and metal stocks trading firm throughout the session....Read More

Markets volatile: ITC, Maruti Suzuki, Asian Paints, Kotak Mahindra Bank, Sun Pharma among other drag the market

Markets volatile: ITC, Maruti Suzuki, Asian Paints, Kotak Mahindra Bank, Sun Pharma among other drag the market

Equity benchmark indices are trading in red after making gains earlier in the day. Sensex dropped by 79.50 points or 0.15 per cent to 51,...Read More

Sun Pharma, Dilip Shanghvi and other officials settle case of alleged market norms violation with Sebi

Sun Pharma, Dilip Shanghvi and other officials settle case of alleged market norms violation with Sebi

Sun Pharmaceutical Industries Ltd and its senior officials, including Managing Director Dilip Shanghvi, on Thursday settled with regulato...Read More

Top stocks: IndusInd Bank, Sun Pharma, PowerGrid, Cipla, Dr Reddy are up more than 4%

Top stocks: IndusInd Bank, Sun Pharma, PowerGrid, Cipla, Dr Reddy are up more than 4%

For the third consecutive day, the stock market is trading in green. At 12.30 pm, Sensex touched a new high at 50,377.15 points and Nift...Read More

Market in green: IndusInd Bank, Dr Reddy's, PowerGrid, Tech Mahindra, Sun Pharma, Axis Bank among top gainers

Market in green: IndusInd Bank, Dr Reddy's, PowerGrid, Tech Mahindra, Sun Pharma, Axis Bank among top gainers

Equity benchmark Sensex pared early losses and turned positive in opening trade on Wednesday amid gains in index-heavyweights Reliance, T...Read More

Sun Pharma Q2 net profit up 70% to Rs 1,813 crore

Sun Pharma Q2 net profit up 70% to Rs 1,813 crore

Drug major Sun Pharmaceutical Industries on Tuesday reported a 70.36 per cent jump in its consolidated net profit to Rs 1,812.79 crore fo...Read More

Market moves up: Sun Pharma, Tech Mahindra, Tata Steel, TCS, Titan, PowerGrid, Reliance Industries among gainers

Market moves up: Sun Pharma, Tech Mahindra, Tata Steel, TCS, Titan, PowerGrid, Reliance Industries among gainers

Domestic equity benchmark Sensex jumped nearly 200 points in early trade on Friday tracking gains in index majors TCS, Reliance Industrie...Read More

COVID-19 in India: Phase 2 clinical trial of Sun Pharma’s AQCH commences

COVID-19 in India: Phase 2 clinical trial of Sun Pharma’s AQCH commences

Pharmaceutical company, Sun Pharma, has commenced Phase 2 clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatmen...Read More

COVID-19 in India: DCGI allows clinical trials of Sun Pharma’s Nafamostat

COVID-19 in India: DCGI allows clinical trials of Sun Pharma’s Nafamostat

Sun Pharmaceutical Industries received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamos...Read More

Sun Pharma Q3 net profit declines 27% to Rs 914 crore

Sun Pharma Q3 net profit declines 27% to Rs 914 crore

The company had posted a net profit of Rs 1,241.85 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE fi...Read More

Free Press Journal

www.freepressjournal.in